CDC Reports Detection and Surveillance of New SARS-CoV-2 Variant BA.3.2
On Mar. 19, 2026, the U.S. Centers for Disease Control and Prevention announced that as of February 11,…
On Mar. 19, 2026, the U.S. Centers for Disease Control and Prevention announced that as of February 11,…
On May 29, 2025, The World Health Organization (WHO), Africa Centres for Disease Control and Prevention (Africa CDC)…
On Jun. 2, 2022, Novavax announced the submission of a request to the Medicines and Healthcare products Regulatory…
On May 20, 2022, Novavax announced the submission of a request to the European Medicines Agency (EMA) to…
On May 18, 2022, Moderna and the nonprofit scientific research organization IAVI announced that the first participant screenings…
Our Heroes and Remembrance illustration has Maurice Ralph Hilleman and John Enders, pioneering developers of common vaccines, and…
On Nov. 29, 2021, Hologic announced that its three SARS-CoV-2 tests all detect the recently emerged Omicron variant of…
On Jun. 28, 2021, the University of Oxford in partnership with AstraZeneca began vaccinations for a new phase…
On Jun. 11, 2021, Novavax announced preclinical and clinical data on the company’s original recombinant protein COVID-19 vaccine…
On May 26, 2021, Altimmune announced new results from a preclinical study demonstrating the ability of its AdCOVID…
On May 25, 2021, ImmunityBio announced two South African studies to examine the potential for using its hAd5…
On May 21, 2021, AstraZeneca announced that it had been granted a special approval for emergency use in…
On May 12, 2021, Inovio Pharma announced that its next-generation Pan-COVID-19 vaccine candidate, INO-4802, induced potent neutralizing antibodies…
On May 5, 2021, Novavax announced the publication of results from the initial primary analysis of a Phase…
On Apr. 9, 2021, the Broad Institute of MIT in partnership with the Centers for Disease Control and…
On Apr. 1, 2021, Kaiser Permanente Washington Health Research Institute (KPWHRI) announced that an investigational vaccine designed to…
On Mar. 31, 2021, the National Institutes of Health (NIH) announced that an investigational vaccine designed to protect against…
On Mar. 22, 2021, Oxford University announced that a Phase III study of the Oxford-AstraZeneca coronavirus vaccine conducted…
On Mar. 19, 2021, scientists at the University of Oxford released pre-print data measuring the level of antibodies…
On Mar. 16, 2021, Roche announced the launch of the cobas SARS-CoV-2 Variant Set 1 Test to detect…
On Mar. 15, 2021, Twist Bioscience announced that it had started shipping its new synthetic RNA reference controls,…
On Mar. 11, 2021, Novavax announced final efficacy of 96.4% against mild, moderate and severe disease caused by…
On Mar. 10, 2021, CEPI, the Coalition for Epidemic Preparedness Innovations, and VBI Vaccines announced a partnership to…
On Mar. 8, 2021, ImmunityBio and NantKwest announced that the first cohorts of their South Africa and U.S….
On Mar. 4, 2021, researchers at the University School of Medicine in St. Louis announced that three new,…
On Mar. 26, 2020, iBio announced that it had entered into a development agreement with AzarGen Biotechnologies. Signed in…
On Apr. 17, 2013, an international team of researchers has decoded the genome of a creature whose evolutionary…
On May 8, 1980, members of the World Heath Organization (WHO) in Geneva announced that “smallpox had been…
On Dec. 3, 1967, surgeon Christiaan Barnard performed the first human to human heart transplant in Cape Town,…